CUV
Click for more information
0.60% $15.16 clinuvel pharmaceuticals limited

News: CUV Clinuvel Pharmaceuticals Says Afamelanotide Received Positive Opinion For Orphan Drug...

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    24/06/24
    11:20
    Post #: 74456202

    June 24 (Reuters) - Clinuvel Pharmaceuticals Ltd (CUV) :

    • DRUG AFAMELANOTIDE RECEIVED POSITIVE OPINION FOR ORPHAN DRUG DESIGNATION FROM EUROPEAN MEDICINES AGENCY

    (([email protected];))

    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS The psychology of spending: How to manage finances wisely
right-arrow Created with Sketch.
NEWS Rate cuts, assassination attempts, gold, oil, AI – what to watch in USA this week
right-arrow Created with Sketch.
NEWS Outstanding metallurgical results significantly de-risk Mandilla gold project
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
NEWS ENR: Most viewed thread today
right-arrow Created with Sketch.
NEWS Gold resource at Minyari Dome grows by 33% – discover the multi-metal potential
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.16 		Change
0.090(0.60%) 		Mkt cap ! $759.1M
Open High Low Value Volume
$15.12 $15.44 $15.02 $1.063M 70.10K

Buyers (Bids)

No. Vol. Price($)
1 126 $15.14
 

Sellers (Offers)

Price($) Vol. No.
$15.27 764 3
View Market Depth
Last trade - 16.10pm 17/09/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.